Deerfield Management as of Sept. 30, 2017
Portfolio Holdings for Deerfield Management
Deerfield Management holds 90 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Avexis | 6.7 | $150M | 1.5M | 96.73 | |
| McKesson Corporation (MCK) | 5.3 | $119M | 772k | 153.61 | |
| Mylan Nv | 4.5 | $99M | 3.2M | 31.37 | |
| Horizon Pharma | 4.0 | $88M | 6.9M | 12.68 | |
| Glaukos (GKOS) | 3.8 | $83M | 2.5M | 33.00 | |
| Dex (DXCM) | 3.1 | $70M | 1.4M | 48.92 | |
| Mallinckrodt Pub | 3.1 | $70M | 1.9M | 37.37 | |
| Horizon Pharma Plc convertible security | 3.0 | $67M | 74M | 0.90 | |
| Myokardia | 2.6 | $59M | 1.4M | 42.85 | |
| Isis Pharmaceuticals Inc Del note 1.000%11/1 | 2.2 | $48M | 46M | 1.06 | |
| Kempharm Inc note 5.500% 2/0 | 2.1 | $46M | 75M | 0.61 | |
| NxStage Medical | 2.0 | $44M | 1.6M | 27.60 | |
| Audentes Therapeutics | 1.9 | $43M | 1.5M | 28.01 | |
| Editas Medicine (EDIT) | 1.9 | $41M | 1.7M | 24.01 | |
| Aclaris Therapeutics (ACRS) | 1.8 | $41M | 1.6M | 25.81 | |
| Intercept Pharmas conv | 1.8 | $40M | 51M | 0.78 | |
| Trn 4% 04/01/45 | 1.7 | $38M | 48M | 0.80 | |
| Flamel Technologies Sa (AVDL) | 1.7 | $38M | 3.7M | 10.50 | |
| Intersect Ent | 1.7 | $38M | 1.2M | 31.15 | |
| Gw Pharmaceuticals Plc ads | 1.7 | $37M | 363k | 101.49 | |
| Endologix, Inc. 3.25% 11/01/2020 | 1.6 | $35M | 41M | 0.86 | |
| Nevro Corp note 1.750% 6/0 | 1.5 | $33M | 28M | 1.19 | |
| Aerie Pharmaceuticals | 1.4 | $31M | 633k | 48.60 | |
| Ascendis Pharma A S (ASND) | 1.4 | $31M | 850k | 36.25 | |
| Anaptysbio Inc Common (ANAB) | 1.3 | $29M | 824k | 34.95 | |
| Natera (NTRA) | 1.3 | $28M | 2.2M | 12.89 | |
| Dbv Technologies S A (DBVT) | 1.2 | $28M | 656k | 42.44 | |
| Insulet Corporation (PODD) | 1.2 | $27M | 497k | 55.08 | |
| Arena Pharmaceuticals | 1.2 | $27M | 1.1M | 25.50 | |
| Lannett Company | 1.2 | $27M | 1.5M | 18.45 | |
| BioCryst Pharmaceuticals (BCRX) | 1.2 | $26M | 5.0M | 5.24 | |
| K2m Group Hldgs Inc bond | 1.1 | $24M | 20M | 1.22 | |
| Select Medical Holdings Corporation (SEM) | 1.0 | $23M | 1.2M | 19.20 | |
| Acceleron Pharma | 1.0 | $23M | 615k | 37.32 | |
| Patterson Companies (PDCO) | 1.0 | $22M | 566k | 38.65 | |
| Fluidigm Corporation convertible cor | 0.9 | $20M | 28M | 0.73 | |
| Syros Pharmaceuticals | 0.8 | $19M | 1.3M | 14.72 | |
| Molina Healthcare (MOH) | 0.8 | $18M | 258k | 68.76 | |
| Aac Holdings | 0.8 | $17M | 1.7M | 9.93 | |
| Selecta Biosciences (RNAC) | 0.8 | $17M | 952k | 18.25 | |
| Recro Pharma (SCTL) | 0.8 | $17M | 1.9M | 8.98 | |
| Portola Pharmaceuticals | 0.7 | $16M | 299k | 54.03 | |
| Synlogic | 0.7 | $16M | 850k | 19.01 | |
| eHealth (EHTH) | 0.7 | $16M | 673k | 23.89 | |
| Oxford Immunotec Global | 0.7 | $16M | 946k | 16.80 | |
| Amag Pharmaceuticals Inc note 2.500% 2/1 | 0.7 | $16M | 16M | 0.97 | |
| Loxo Oncology | 0.7 | $16M | 169k | 92.12 | |
| Ardelyx (ARDX) | 0.7 | $15M | 2.7M | 5.60 | |
| Advanced Accelerat spon ads each rep 2 ord | 0.7 | $15M | 218k | 67.62 | |
| Neos Therapeutics | 0.7 | $14M | 1.6M | 9.15 | |
| Blueprint Medicines (BPMC) | 0.6 | $14M | 203k | 69.67 | |
| Agios Pharmaceuticals (AGIO) | 0.6 | $14M | 208k | 66.75 | |
| Cytomx Therapeutics (CTMX) | 0.6 | $14M | 757k | 18.17 | |
| Epizyme | 0.6 | $13M | 701k | 19.05 | |
| Galapagos Nv- (GLPG) | 0.6 | $13M | 130k | 101.75 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.6 | $13M | 17M | 0.80 | |
| Wave Life Sciences (WVE) | 0.6 | $13M | 580k | 21.75 | |
| Xencor (XNCR) | 0.5 | $12M | 522k | 22.92 | |
| Argenx Se (ARGX) | 0.5 | $12M | 509k | 22.61 | |
| Alpine Immune Sciences (ALPN) | 0.5 | $11M | 933k | 11.60 | |
| Invuity | 0.5 | $11M | 1.2M | 8.90 | |
| Allscripts Healthcare So conv | 0.5 | $10M | 9.7M | 1.06 | |
| Sangamo Biosciences (SGMO) | 0.4 | $9.8M | 653k | 15.00 | |
| Centene Corporation (CNC) | 0.4 | $9.9M | 102k | 96.77 | |
| Invitae (NVTAQ) | 0.4 | $8.4M | 900k | 9.37 | |
| Immunomedics | 0.4 | $8.1M | 582k | 13.98 | |
| Alimera Sciences | 0.4 | $8.2M | 6.1M | 1.35 | |
| Marinus Pharmaceuticals | 0.4 | $8.0M | 1.4M | 5.87 | |
| Nucana Plc american depositary shares (NCNA) | 0.3 | $7.8M | 425k | 18.37 | |
| Clementia | 0.3 | $7.8M | 462k | 16.89 | |
| Axovant Sciences | 0.3 | $7.2M | 1.1M | 6.88 | |
| Axogen (AXGN) | 0.3 | $6.7M | 344k | 19.35 | |
| Myovant Sciences | 0.3 | $6.2M | 401k | 15.47 | |
| Biohaven Pharmaceutical Holding | 0.3 | $6.2M | 165k | 37.38 | |
| Deciphera Pharmaceuticals (DCPH) | 0.3 | $6.2M | 325k | 18.99 | |
| Reata Pharmaceuticals Inc Cl A | 0.3 | $5.9M | 190k | 31.10 | |
| Agile Therapeutics | 0.2 | $5.4M | 1.2M | 4.46 | |
| Steadymed | 0.2 | $4.8M | 1.4M | 3.35 | |
| Foamix Pharmaceuticals | 0.2 | $4.5M | 817k | 5.55 | |
| Sierra Oncology | 0.2 | $4.3M | 2.8M | 1.55 | |
| Sage Therapeutics (SAGE) | 0.2 | $4.2M | 68k | 62.29 | |
| Aralez Pharmaceuticals | 0.2 | $3.8M | 1.6M | 2.29 | |
| Obalon Therapeutics | 0.1 | $3.3M | 351k | 9.53 | |
| BioScrip | 0.1 | $3.0M | 1.1M | 2.75 | |
| Akari Therapeutics | 0.1 | $2.7M | 434k | 6.14 | |
| Proteon Therapeutics | 0.1 | $2.4M | 1.2M | 2.00 | |
| Voyager Therapeutics (VYGR) | 0.1 | $2.4M | 118k | 20.59 | |
| MiMedx (MDXG) | 0.1 | $1.8M | 150k | 11.88 | |
| Intra Cellular Therapies (ITCI) | 0.1 | $1.9M | 118k | 15.78 | |
| Ra Pharmaceuticals | 0.1 | $1.5M | 102k | 14.60 |
